Annals of vascular surgery · 2025
Robotic Median Arcuate Ligament Release May Offer Superior Symptom Improvement to Laparoscopic Release.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fay Kayla A, Stableford Jennifer A, Columbo Jesse A, Stone David H, Finley David J
Аннотация
BACKGROUND: Median arcuate ligament (MAL) syndrome is a challenging disease process to treat. Laparoscopic ligament release can lead to early symptom improvement, but symptom recurrence is common. Recently, these MAL releases are being performed robotically at select institutions. The purpose of this study was to document symptom resolution and recurrence rates after laparoscopic and robotic MAL release (r-MALR) at our institution.
METHODS: We performed a retrospective review of all patients treated with minimally invasive MAL release at a single academic tertiary medical center from 2017-2023. We stratified patients by operative approach, laparoscopic versus robotic. Our primary outcome was symptom resolution at 6-month follow-up.
RESULTS: We identified 38 patients who underwent MAL release, 27 (71.1%) that underwent laparoscopic release, and 11 (28.9%) that underwent r-MALR. Preoperative characteristics were similar between groups, including age (37.0 years vs. 41.1 years, P = 0.45) and preoperative psychiatric diagnosis (60.0% vs. 36.4%, P = 0.28). Patients who underwent an r-MALR had a higher likelihood of postoperative symptom resolution when compared to those who underwent a laparoscopic release at both 1 month (81.8% vs. 20%, P = 0.001) and 6 months (54.5% vs. 4%, P = 0.001). Postoperative length of stay was lower in the laparoscopic group (median 0 days vs. 1 day, P = 0.03), and there were more frequent reports of new postoperative gastrointestinal symptoms after r-MALR (27.3% v. 4.0%, P = 0.08).
CONCLUSION: At 1-month and 6-months postoperatively r-MALR was associated with improved symptom resolution when compared to laparoscopic release. For patients who have this challenging disease entity, r-MALR should be considered.
METHODS: We performed a retrospective review of all patients treated with minimally invasive MAL release at a single academic tertiary medical center from 2017-2023. We stratified patients by operative approach, laparoscopic versus robotic. Our primary outcome was symptom resolution at 6-month follow-up.
RESULTS: We identified 38 patients who underwent MAL release, 27 (71.1%) that underwent laparoscopic release, and 11 (28.9%) that underwent r-MALR. Preoperative characteristics were similar between groups, including age (37.0 years vs. 41.1 years, P = 0.45) and preoperative psychiatric diagnosis (60.0% vs. 36.4%, P = 0.28). Patients who underwent an r-MALR had a higher likelihood of postoperative symptom resolution when compared to those who underwent a laparoscopic release at both 1 month (81.8% vs. 20%, P = 0.001) and 6 months (54.5% vs. 4%, P = 0.001). Postoperative length of stay was lower in the laparoscopic group (median 0 days vs. 1 day, P = 0.03), and there were more frequent reports of new postoperative gastrointestinal symptoms after r-MALR (27.3% v. 4.0%, P = 0.08).
CONCLUSION: At 1-month and 6-months postoperatively r-MALR was associated with improved symptom resolution when compared to laparoscopic release. For patients who have this challenging disease entity, r-MALR should be considered.